300 related articles for article (PubMed ID: 9813052)
21. Growth hormone, but not insulin, activates STAT5 proteins in adipocytes in vitro and in vivo.
Zvonic S; Story DJ; Stephens JM; Mynatt RL
Biochem Biophys Res Commun; 2003 Mar; 302(2):359-62. PubMed ID: 12604355
[TBL] [Abstract][Full Text] [Related]
22. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes.
Kodama H; Fukuda K; Pan J; Makino S; Baba A; Hori S; Ogawa S
Circ Res; 1997 Nov; 81(5):656-63. PubMed ID: 9351438
[TBL] [Abstract][Full Text] [Related]
23. Cytokine signal transduction in P19 embryonal carcinoma cells: regulation of Stat3-mediated transactivation occurs independently of p21ras-Erk signaling.
van Puijenbroek AA; van der Saag PT; Coffer PJ
Exp Cell Res; 1999 Sep; 251(2):465-76. PubMed ID: 10471331
[TBL] [Abstract][Full Text] [Related]
24. Differential activation of the extracellular signal-regulated kinase, Jun kinase and Janus kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells.
Faris M; Ensoli B; Stahl N; Yancopoulos G; Nguyen A; Wang S; Nel AE
AIDS; 1996 Apr; 10(4):369-78. PubMed ID: 8728040
[TBL] [Abstract][Full Text] [Related]
25. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
26. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells.
Levy JB; Schindler C; Raz R; Levy DE; Baron R; Horowitz MC
Endocrinology; 1996 Apr; 137(4):1159-65. PubMed ID: 8625884
[TBL] [Abstract][Full Text] [Related]
27. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
Ray DW; Ren SG; Melmed S
J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
[TBL] [Abstract][Full Text] [Related]
28. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
Bousquet C; Susini C; Melmed S
J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
[TBL] [Abstract][Full Text] [Related]
30. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
Piekorz RP; Hocke GM
Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
[TBL] [Abstract][Full Text] [Related]
31. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology.
Ng DC; Long CS; Bogoyevitch MA
J Biol Chem; 2001 Aug; 276(31):29490-8. PubMed ID: 11382751
[TBL] [Abstract][Full Text] [Related]
32. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
Yu CL; Meyer DJ; Campbell GS; Larner AC; Carter-Su C; Schwartz J; Jove R
Science; 1995 Jul; 269(5220):81-3. PubMed ID: 7541555
[TBL] [Abstract][Full Text] [Related]
33. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
[TBL] [Abstract][Full Text] [Related]
34. Leukemia inhibitory factor as a mediator of JAK/STAT activation in murine osteoblasts.
Lowe C; Gillespie GA; Pike JW
J Bone Miner Res; 1995 Nov; 10(11):1644-50. PubMed ID: 8592940
[TBL] [Abstract][Full Text] [Related]
35. The identification and characterization of a STAT 1 binding site in the PPARgamma2 promoter.
Hogan JC; Stephens JM
Biochem Biophys Res Commun; 2001 Sep; 287(2):484-92. PubMed ID: 11554754
[TBL] [Abstract][Full Text] [Related]
36. Induction of an interferon-gamma Stat3 response in nerve cells by pre-treatment with gp130 cytokines.
Kaur N; Kim IJ; Higgins D; Halvorsen SW
J Neurochem; 2003 Oct; 87(2):437-47. PubMed ID: 14511121
[TBL] [Abstract][Full Text] [Related]
37. Leukemia inhibitory factor enhances mast cell growth in a mast cell/fibroblast co-culture system through stat3 signaling pathway of fibroblasts.
Hiragun T; Morita E; Mihara S; Tanaka T; Gyotoku E; Kameyoshi Y; Yamamoto S
FEBS Lett; 2000 Dec; 487(2):219-23. PubMed ID: 11150513
[TBL] [Abstract][Full Text] [Related]
38. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
Bellido T; Borba VZ; Roberson P; Manolagas SC
Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
[TBL] [Abstract][Full Text] [Related]
39. Oncostatin M induces tissue-type plasminogen activator and plasminogen activator inhibitor-1 in Calu-1 lung carcinoma cells.
Spence MJ; Streiff R; Day D; Ma Y
Cytokine; 2002 Apr; 18(1):26-34. PubMed ID: 12090757
[TBL] [Abstract][Full Text] [Related]
40. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
